26 related articles for article (PubMed ID: 18783539)
1. The role of phosphatidylethanolamine methyltransferase in a mouse model of intrahepatic cholestasis.
Li Z; Agellon LB; Vance DE
Biochim Biophys Acta; 2011 Apr; 1811(4):278-83. PubMed ID: 21292027
[TBL] [Abstract][Full Text] [Related]
2. Novel mutation in progressive familial intrahepatic cholestasis III.
Chinnaratha MA; Venugopal K; de Boer WB; Macquillan G
Liver Int; 2013 Sep; 33(8):1293. PubMed ID: 23574360
[No Abstract] [Full Text] [Related]
3. Improvement of hepatocyte transplantation efficiency in the mdr2-/- mouse model by glyceryl trinitrate.
Boudechiche L; Tranchart H; Branchereau S; Davit-Spraul A; Laïnas P; Groyer-Picard MT; Weber A; Hadchouel M; Dagher I
Transplantation; 2015 Jan; 99(1):36-40. PubMed ID: 25340599
[TBL] [Abstract][Full Text] [Related]
4. The histidine-loop is essential for transport activity of human MDR3. A novel mutation of MDR3 in a patient with progressive familial intrahepatic cholestasis type 3.
Dzagania T; Engelmann G; Häussinger D; Schmitt L; Flechtenmacher C; Rtskhiladze I; Kubitz R
Gene; 2012 Sep; 506(1):141-5. PubMed ID: 22766396
[TBL] [Abstract][Full Text] [Related]
5. Effects of bezafibrate on dyslipidemia with cholestasis in children with familial intrahepatic cholestasis-1 deficiency manifesting progressive familial intrahepatic cholestasis.
Nagasaka H; Yorifuji T; Hirano K; Ota A; Toyama-Nakagawa Y; Takatani T; Tsukahara H; Kobayashi K; Takayanagi M; Inomata Y; Uemoto S; Miida T
Metabolism; 2009 Jan; 58(1):48-54. PubMed ID: 19059530
[TBL] [Abstract][Full Text] [Related]
6. Turning over or turning around: hepatic phosphatidylcholine in the mouse model for progressive familial intrahepatic cholestasis type 3.
Stieger B
Liver Int; 2008 Aug; 28(7):908-10. PubMed ID: 18783539
[No Abstract] [Full Text] [Related]
7. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
8. [Progressive familial intrahepatic cholestasis type 3].
Fang LJ; Wang JS
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):238-40. PubMed ID: 20380808
[No Abstract] [Full Text] [Related]
9. Manipulation of biliary lipids by gene therapy: potential consequences for patients with progressive familial intrahepatic cholestasis.
Oude Elferink RP
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):199-202. PubMed ID: 16089353
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
Semin Liver Dis; 2010 May; 30(2):134-46. PubMed ID: 20422496
[TBL] [Abstract][Full Text] [Related]
11. The secretory function of the liver: new aspects of hepatobiliary transport.
Müller M; Jansen PL
J Hepatol; 1998 Feb; 28(2):344-54. PubMed ID: 9514549
[No Abstract] [Full Text] [Related]
12. [Hepatobiliary transporters: from genomics to diseases].
Rosmorduc O; Poupon R
Gastroenterol Clin Biol; 2004 May; 28(5 Suppl):D112-20. PubMed ID: 15213671
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
